STU:T9G (UK)
Registered Shares
€
0.49
-0.040 (-7.55%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Vidac Pharma Holding PLC
ISIN : GB00BM9XQ619
Share Class Description:
STU:T9G: Registered SharesCompare
Compare
Traded in other countries / regions
T9G.Germany IPO Date
2023-08-07Description
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | -10.43 | |||||
| Debt-to-Equity | -0.29 | |||||
| Debt-to-EBITDA | -0.24 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.66 | |||||
| 9-Day RSI | 41.14 | |||||
| 14-Day RSI | 41.67 | |||||
| 3-1 Month Momentum % | -27.56 | |||||
| 6-1 Month Momentum % | -8.87 | |||||
| 12-1 Month Momentum % | 135.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.59 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1575 | |||||
| ROIC % | -540 | |||||
| ROC (Joel Greenblatt) % | -34200 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -19.64 | |||||
| EV-to-Forward-EBIT | -13.85 | |||||
| EV-to-EBITDA | -19.64 | |||||
| EV-to-Forward-EBITDA | -13.85 | |||||
| EV-to-FCF | -23.81 | |||||
| Earnings Yield (Greenblatt) % | -5.09 | |||||
| FCF Yield % | -4.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Vidac Pharma Holding PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.027 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 132.78 | ||
| 14-Day RSI | 41.67 | ||
| 14-Day ATR (€) | 0.056653 | ||
| 20-Day SMA (€) | 0.532 | ||
| 12-1 Month Momentum % | 135.42 | ||
| 52-Week Range (€) | 0.155 - 1.3 | ||
| Shares Outstanding (Mil) | 54.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vidac Pharma Holding PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vidac Pharma Holding PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vidac Pharma Holding PLC Frequently Asked Questions
What is Vidac Pharma Holding PLC(STU:T9G)'s stock price today?
The current price of STU:T9G is €0.49. The 52 week high of STU:T9G is €1.30 and 52 week low is €0.16.
When is next earnings date of Vidac Pharma Holding PLC(STU:T9G)?
The next earnings date of Vidac Pharma Holding PLC(STU:T9G) is .
Does Vidac Pharma Holding PLC(STU:T9G) pay dividends? If so, how much?
Vidac Pharma Holding PLC(STU:T9G) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers